Negative-pressure system incorporating wound diagnostic capabilities
A therapy system for treating a tissue site with negative-pressure therapy and/or fluid instillation therapy in response to information received from a diagnostic module is described. The therapy system may include a dressing, a negative-pressure source, a container, and a diagnostic module. The dressing be placed on the tissue site, and the negative-pressure source may be fluidly coupled to the dressing. The container may be fluidly coupled to the dressing and to the negative-pressure source to receive fluid from the tissue site. The diagnostic module may be exposed to gas associated with the fluid from the tissue site. The diagnostic module may comprise a sensor configured to detect a condition of the tissue site and to generate an output based on the detected condition. The sensor may be configured to detect a volatile organic compound. The diagnostic module may be positioned on the container.
1. A system for treating a tissue site, comprising:
a dressing adapted to be placed on the tissue site;
a negative-pressure source adapted to be fluidly coupled to the dressing;
a container having a fluid inlet adapted to be fluidly coupled to the dressing, a fluid outlet adapted to be fluidly coupled to the negative-pressure source, and a collection chamber to receive fluid from the tissue site
a sensor compartment disposed within the container between the collection chamber and the fluid outlet, the sensor compartment having a fluid pathway fluidly coupled to the fluid outlet and a purge pathway configured to be fluidly coupled to an ambient environment;
a sensor module removably positioned in the fluid pathway of the sensor compartment and adapted to be exposed to gas associated with the fluid from the tissue site, wherein the sensor module comprises a first sensor configured to detect a condition of the tissue site and to generate a first output based on the detected condition;
a transceiver electrically coupled to the sensor module and configured to transmit the first output from the sensor module; and
a controller configured to:
receive the first output from the transceiver;
generate a data entry based on the detected condition; and
in response to the detected condition, adjust a provided therapy.
2. The system of claim 1 , wherein the first sensor is configured to detect a first volatile organic compound.
3. The system of claim 2 , wherein the first volatile organic compound comprises a bacterial component.
4. The system of claim 2 , wherein the first volatile organic compound comprises a protease component.
5. The system of claim 2 , wherein the first volatile organic compound comprises a matrix metalloproteinase component.
6. The system of claim 2 , wherein the first sensor is any one of an acoustic wave gas sensors, a resistive gas sensor, a photoelectric gas sensor, and an optical gas sensor for detecting a volatile organic compound.
7. The system of claim 2 , where the first sensor is a FAIMS sensor for detecting a volatile organic compound.
8. The system of claim 1 , wherein:
the first sensor is configured to detect a first volatile organic compound; and
the sensor module further comprises a second sensor configured to detect a second volatile organic compound.
9. The system of claim 1 , wherein the first sensor comprises a metal-oxide semiconductor sensor.
10. The system of claim 1 , wherein the first sensor is configured to detect a first volatile organic compound indicative of the detected condition.
11. The system of claim 10 , wherein the first volatile organic compound comprises a protease component.
12. The system of claim 11 , wherein the detected condition is a normal wound healing condition.
13. The system of claim 12 , wherein the normal wound healing condition is indicated by a predetermined low protease activity level.
14. The system of claim 12 , wherein the normal wound healing condition is indicated by a protease activity level the changes from a increasing value to a decreasing value.
15. The system of claim 11 , wherein the detected condition is a non-healing wound condition.
16. The system of claim 15 , wherein the non-healing wound condition is indicated by a predetermined high protease activity level.
17. The system of claim 15 , further comprising an instillation source adapted to be fluidly coupled to the dressing and configured to provide any instillation fluid comprising a collagen/ORC slurry when the non-healing wound condition is indicated.